Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:704-712

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Theriault, A.
Right arrow Articles by Adeli, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theriault, A.
Right arrow Articles by Adeli, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-METHIONINE
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Risk Factors
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:704-712.)
© 1999 American Heart Association, Inc.


Original Contributions

Effects of {gamma}-Tocotrienol on ApoB Synthesis, Degradation, and Secretion in HepG2 Cells

Andre Theriault; Qi Wang; Abdul Gapor; Khosrow Adeli

From the Division of Medical Technology (A.T., Q.W.), University of Hawaii at Manoa, Honolulu; Palm Oil Research Institute of Malaysia (A.G.), Kuala Lumpur; and Department of Laboratory Medicine, Hospital for Sick Children, University of Toronto (K.A.), Canada.

Correspondence to A. Theriault, Division of Medical Technology, University of Hawaii at Manoa, 1960 East-West Rd, Bio C-206, Honolulu, HI 96822. E-mail andret{at}hawaii.edu

Abstract{gamma}-Tocotrienol ({gamma}-T3), a naturally occurring analog of tocopherol (vitamin E), has been shown to have a hypocholesterolemic effect in animals and humans. Unlike tocopherol, it has also been shown to reduce plasma apoB levels in hypercholesterolemic subjects. The aim of this study was to define the mechanism of action of {gamma}-T3 on hepatic modulation of apoB production using cultured HepG2 cells as the model system. HepG2 cells preincubated with {gamma}-T3 were initially shown to inhibit the rate of incorporation of [14C]acetate into cholesterol in a concentration- and time-dependent manner, with a maximum 86±3% inhibition at 50 µmol/L observed within 6 hours. {gamma}-T3, on the other hand, had no significant effect on the uptake of [14C]glycerol into pools of cellular triacylglycerol and phospholipid relative to untreated control. The rate of apoB synthesis and secretion was then studied by an [35S]methionine pulse-labeling experiment and quantified by immunoprecipitating apoB on chasing up to 3 hours. An average reduction of 24±3% in labeled apoB in the media was apparent with {gamma}-T3 despite a 60±2% increase in apoB synthesis. Fractionation of secreted apoB revealed a relatively denser lipoprotein particle, suggesting a less stable particle. Using a digitonin-permeabilized HepG2 cell system, the effects of {gamma}-T3 on apoB translocation and degradation in the endoplasmic reticulum were further investigated. The generation of a specific N-terminal 70-kDa proteolytic fragment proved to be a sensitive measure of the rate of apoB translocation and degradation. The abundance of this fragment increased significantly in {gamma}-T3-treated cells relative to untreated control cells (50±21%) after 2 hours of chase. In addition, the presence of {gamma}-T3 resulted in an average decrease of 64±8% in intact apoB. Taken together, the data suggest that {gamma}-T3 stimulates apoB degradation possibly as the result of decreased apoB translocation into the endoplasmic reticulum lumen. It is speculated that the lack of cholesterol availability reduces the number of secreted apoB-containing lipoprotein particles by limiting translocation of apoB into the endoplasmic reticulum lumen.


Key Words: apoB • tocotrienol • tocopherol • HMG-CoA reductase inhibitor • degradation




This article has been cited by other articles:


Home page
J. Nutr.Home page
A. Casaschi, G. K. Maiyoh, B. K. Rubio, R. W. Li, K. Adeli, and A. G. Theriault
The Chalcone Xanthohumol Inhibits Triglyceride and Apolipoprotein B Secretion in HepG2 Cells
J. Nutr., June 1, 2004; 134(6): 1340 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Zu and C. Ip
Synergy between Selenium and Vitamin E in Apoptosis Induction Is Associated with Activation of Distinctive Initiator Caspases in Human Prostate Cancer Cells
Cancer Res., October 15, 2003; 63(20): 6988 - 6995.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Ikeda, T. Tohyama, H. Yoshimura, K. Hamamura, K. Abe, and K. Yamashita
Dietary {alpha}-Tocopherol Decreases {alpha}-Tocotrienol but Not {gamma}-Tocotrienol Concentration in Rats
J. Nutr., February 1, 2003; 133(2): 428 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. A.J.M. Kerckhoffs, F. Brouns, G. Hornstra, and R. P. Mensink
Effects on the Human Serum Lipoprotein Profile of {beta}-Glucan, Soy Protein and Isoflavones, Plant Sterols and Stanols, Garlic and Tocotrienols
J. Nutr., September 1, 2002; 132(9): 2494 - 2505.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Theriault, Q. Wang, S. C. Van Iderstine, B. Chen, A. A. Franke, and K. Adeli
Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid
J. Lipid Res., December 1, 2000; 41(12): 1969 - 1979.
[Abstract] [Full Text]